MESOTHELIOMA RESEARCH
Yesterday I alluded to the fact that, for a research project to provide valuable data, the more people included in the research the better. Of course, the number of research subjects isn't the only consideration. For instance, like must be compared with like - when researching the efficacy of a drug, there is little point in including all types of mesothelioma. The drug may be very good for, say, pleural mesothelioma but useless for peritoneal mesothelioma but including the two types of disease within the same research project will skew the figures and the true facts will not be discovered.
With the example just quoted, researchers would come to the conclusion that the drug worked moderately well across the mesothelioma range included. From that they might report that, economically, it was not worthwhile offering the drug at all when the truth of the matter was that it was very worthwhile for pleural mesothelioma.
I spent many years in medical research, although in a different branch of medicine (pregnancy and childbirth), and I thought that for the next week or so it might be interesting to look critically at some of the research into asbestos and mesothelioma. So, we'll start Wednesday!
You may want to click on the following link to see some of the projects we might look at...
